Investment Pitches

Pitch Summary:
U.S. based MKS Inc. delivered on earnings and guidance, driven by accelerating AI demand across semiconductor and advanced electronics end markets. Investors also appreciated MKS’ efforts to sell its specialty chemical business and focus on core products. The company benefited from strong demand tied to advanced chip manufacturing. Portfolio simplification further improved sentiment.

BSD Analysis:
MKS is a critical supplier to semiconductor manufacturing, providing precision components that fabs cannot run without. Its exposure to advanced nodes and process complexity gives it leverage as chips get harder to make. The business is cyclical, but installed-base service revenue cushions downturns. AI and advanced packaging increase demand for MKS’s most sophisticated products. Integration from past acquisitions adds execution risk, but also scale benefits. Margins reflect technical differentiation rather than volume chasing. Customer concentration exists, but switching costs are real. This is semiconductor plumbing, not headline tech. When capex returns, MKS snaps back hard.

Pitch Summary:
SK Hynix and Samsung Electronics, the two largest global memory manufacturers in Korea, were the top two contributors for the quarter, topping IT sector results. Supply-demand constraints benefit memory chip suppliers; the market expects memory price increases in 2026, further supporting the performance of Samsung and SK Hynix. Strong demand for AI memory technology has tightened supply conditions, allowing pricing to rise across DRAM and high-bandwidth memory markets. The improving pricing environment has driven earnings upgrades and investor confidence. These dynamics position SK Hynix favorably heading into 2026.

BSD Analysis:
SK hynix sits directly at the center of the AI compute boom through its dominance in high-bandwidth memory. HBM is no longer niche — it’s mission-critical, and supply is tight. Memory is still cyclical, but this cycle looks structurally different due to AI-driven demand persistence. Capital intensity is brutal, but returns explode when pricing tightens. Technology leadership matters more now than ever, and SK hynix has it. Volatility is not a bug — it’s the entry fee. This is not a sleep-well-at-night stock. It’s controlled leverage to AI infrastructure. When it works, it works fast.

Pitch Summary:
Jazz Pharmaceuticals announced record quarterly revenues driven by Epidiolex and Xywav. The company also received FDA approvals for two drugs and reported positive Phase 3 trial results for its potential blockbuster HER2+ cancer treatment Ziihera. These developments significantly improved long-term growth visibility. Strong execution across both commercial and pipeline assets supported investor confidence.

BSD Analysis:
Jazz is a cash-generating specialty pharma company often miscast as a single-asset story. Its core franchise throws off durable free cash flow that funds pipeline expansion internally. Recent acquisitions broaden therapeutic exposure without blowing up the balance sheet. Investors worry about patent concentration more than execution quality. Commercial infrastructure is already in place, lowering incremental risk. R&D productivity matters more than headline growth. This is pharma built on cash discipline, not binary science bets. Boring pipelines still compound.

Pitch Summary:
Honda benefited from resilient global demand and improving operational execution. While not a top contributor, the company participated in broader Japanese equity strength. Management continues to focus on shareholder returns and disciplined capital allocation. The stock reflects improving confidence in earnings stability.

BSD Analysis:
Honda is an engineering-driven manufacturer prioritizing balance-sheet strength over flashy disruption narratives. Its hybrid strategy looks increasingly pragmatic as EV adoption proves uneven. Motorcycles remain a global cash engine investors often ignore. Automotive margins are pressured, but capital discipline limits downside. Investors lump Honda in with legacy auto decline stories. That ignores brand trust, scale, and engineering depth. Optionality exists in electrification without existential bets. This is industrial resilience, not tech cosplay.

Pitch Summary:
Capgemini advanced 15% after announcing better-than-expected quarterly revenues. Demand has been driven by cloud migration, data analytics and AI-related projects, with clients increasingly focused on efficiency and optimization initiatives. The company’s ability to deliver cost-saving and productivity-enhancing solutions resonated strongly with customers. These trends supported improved revenue visibility and margin resilience. We believe Capgemini remains well positioned as enterprises prioritize digital efficiency.

BSD Analysis:
Capgemini is a quiet beneficiary of enterprise digital transformation that prioritizes execution over hype. Clients rely on it to modernize core systems, not chase experimental tech trends. Demand slows in weak macro environments, but outsourcing and efficiency mandates create a floor. AI and cloud projects increasingly favor incumbents with delivery scale and trust. Investors treat IT services as low-growth labor arbitrage. That misses Capgemini’s move up the value chain toward consulting and managed services. Margins reflect operational discipline rather than pricing heroics. This is enterprise modernization sold on reliability, not buzzwords.

Pitch Summary:
Samsung Electronics was a top contributor alongside SK Hynix as improving memory market fundamentals supported performance. Supply-demand constraints are expected to lead to memory price increases in 2026, benefiting large-scale producers. Samsung’s scale, technology leadership and exposure to AI-driven memory demand underpin its recovery. Investor confidence improved as the market began to discount a cyclical upturn combined with long-term AI tailwinds.

BSD Analysis:
Samsung is memory cyclicality wrapped inside one of the strongest balance sheets in global tech. Earnings swing violently, but survival is never in doubt, which already separates it from weaker peers. AI-driven demand for advanced memory is reshaping the profit curve, even if timing remains uneven. Investors anchor to old boom-bust scars and underestimate how supply discipline has improved across the industry. Foundry ambitions add long-term optionality, even if margins lag today. Consumer electronics provide steady cash flow, not growth optics. When memory tightens, Samsung’s earnings snap back fast. This is optionality on patience, not a straight-line story.

Pitch Summary:
SK Hynix was one of the top contributors for the quarter, benefiting from tightening supply-demand dynamics in global memory markets. Supply constraints are favoring memory chip suppliers, and the market increasingly expects memory price increases in 2026. These dynamics have materially improved sentiment toward memory manufacturers. SK Hynix’s exposure to AI-related workloads and high-performance memory positions it well for continued demand strength. We believe improving pricing power and utilization will support earnings momentum into 2026.

BSD Analysis:
SK hynix is at the center of the AI memory boom, supplying high-bandwidth memory that accelerators can’t function without. HBM demand is reshaping the memory cycle, potentially making it longer and more profitable. The business remains cyclical, but supply discipline is better than history suggests. Capital intensity is extreme, which magnifies both wins and losses. Technology leadership in advanced memory nodes gives SK hynix an edge over weaker players. Volatility is the entry price. This is not a steady compounder — it’s torque with fundamentals. If AI spending holds, SK hynix prints money.

Pitch Summary:
TFI International released earnings at the end of October. The company beat on EPS, but they missed consensus on revenue and dealt with the continued deceleration in the North American freight market. Renewed optimism regarding a subsequent recovery of the freight market lifted the stock prices in the transportation industry in both sides of the border. Specifically to TFII, continued improvement on their US operations with quarter-to-quarter lowered Operating Ratios (OR) helped investors' confidence on management’s ability to turn the segment around. Finally, free cash flow generation continued to increase despite lower earnings, helping TFI maintain a strong financial position.

BSD Analysis:
TFI International is a logistics consolidator that thrives on chaos, not stability. Its decentralized model allows acquired businesses to keep entrepreneurial edge while benefiting from scale. Pricing discipline and cost control are cultural, not cyclical. Freight markets are volatile, but TFI uses downturns to buy assets cheap. Cash generation is strong and reinvested aggressively. Management is ruthless about returns. Growth comes from execution, not macro tailwinds. This is a compounder built on operational intensity. Boring trucks, exceptional returns.

Pitch Summary:
Canadian Imperial Bank of Commerce (CM) is Canada's fifth-largest bank, operating within an oligopoly that has consistently compounded shareholder value over decades. The banks in Canada are heavily regulated on both the credit requirements and reserves, with CIBC maintaining a strong 13.4% CET1 ratio that provides a robust buffer against additional regulatory requirements. CIBC offers a distinct investment profile among the Big 6, with a de-risked strategy that focuses primarily on domestic personal and commercial banking. This domestic focus is complemented by a high-quality private wealth franchise and a digital-first expansion that has helped the bank grow profitably. With the highest dividend growth of the peer group over the past two years and a commitment to a 40-50% payout ratio, we believe CIBC is well-positioned to continue delivering reliable dividend growth.

BSD Analysis:
CIBC is the most rate-sensitive of the Canadian banks, which cuts both ways. Higher rates boost margins quickly, but credit cycles hit faster too. The bank’s U.S. exposure adds growth optionality but also complexity. Underwriting discipline has improved after past missteps. Capital levels are solid, supporting dividends. The stock trades at a discount reflecting perceived risk. If credit remains manageable, rerating is possible. This is not the safest bank — it’s the levered one. Upside comes from normalization, not hero growth.

Pitch Summary:
Pet Valu Holdings Ltd. (PET) is Canada’s largest specialty pet retailer, operating an unrivaled network of over 830 stores. With a hybrid model of franchised and corporate stores, Pet Valu maintains a clear runway for growth through new store openings and a long-term goal of 1,200+ locations. Having recently completed a four-year, $100 million capital investment cycle to modernize its national distribution network, the company is now fully equipped to support its next growth chapter with enhanced supply chain efficiencies. We believe this infrastructure, combined with a sticky, large loyalty base, will drive resilient free cash flow and support continued dividend growth.

BSD Analysis:
Pet Valu operates at the intersection of defensive retail and emotional spending, which is a great place to be. Pet ownership spending is resilient because people cut themselves before they cut their pets. The franchise model keeps capital intensity low while aligning incentives at the store level. Private-label products support margin expansion. Competition exists, but local presence and service still matter. Growth is steady rather than explosive, and that’s fine. Cash flow supports reinvestment and debt reduction. This is not a fad retailer. It’s a quiet consumer compounder with teeth.

Pitch Summary:
The Royal Bank of Canada (RY) is Canada's largest bank, with operations across North America and globally and a workforce of more than 100,000 employees. The bank has a leading position in Canadian retail and commercial banking and multiple levers for organic growth. Its diversified business mix helps cushion earnings through interest-rate and credit cycles, while its scale, strong capital position, and long track record of dividend growth support durable shareholder returns. We expect continued acceleration in core business drivers, execution on key growth initiatives, and a supportive housing backdrop to drive resilient earnings growth and sustain dividend growth.

BSD Analysis:
RBC is the gold standard of Canadian banking, combining scale, diversification, and disciplined risk management. Its wealth management and capital markets businesses add earnings resilience beyond plain-vanilla lending. Credit quality has historically been strong, even through economic stress. The bank benefits from oligopolistic market structure that protects margins. Capital levels support dividends and long-term compounding. Regulatory constraints cap upside but also limit downside. RBC doesn’t need heroics to win. It compounds by doing the basics exceptionally well. In banking, that’s the edge.

Pitch Summary:
OpenText released decent earnings on November 5, but apparently not good enough. Earnings per share beat consensus $1.05 vs $0.99 and revenue slightly beat consensus, margins were quite healthy, and free cash flow saw a noticeable year-over-year improvement. The concerns were related to the underlying components of recurring revenue, year over year growth was modest suggesting a slower growth trajectory than high-growth cloud peers. Another perceived negative was the customer support decline of 1.5% which is a core part of Annual Recurring Revenue possibly raising concerns about client retention in the traditional on-premise business. The “Shrink to Grow” strategy - divestiture of non-core assets to focus on higher-growth cloud and AI solutions is a smart move but could impact short-term revenue.

BSD Analysis:
OpenText is enterprise software that survives not because it’s loved, but because it’s embedded and painful to replace. Its content management and information governance tools sit deep inside regulated workflows where switching risk dwarfs licensing cost. Growth is slow, but cash flow is very real, and management knows it. Acquisitions have been the playbook for decades, creating complexity but also durability. The move toward cloud subscriptions improves revenue visibility but compresses margins in the short term. Balance-sheet leverage is a watch item, not a thesis breaker. This is not a sexy SaaS story — it’s software annuity management. If execution stays disciplined, the cash keeps coming. OpenText rewards patience, not excitement.

Pitch Summary:
Thomson Reuters delivered in-line quarter with a beat on EPS and revenue. Headwinds in their government solutions business will likely result at the lower end of the FY25 organic growth range. Free cash flow decline year-over-year was a concern. More importantly, perceived skepticism that AI startups could disrupt the business model has hurt its stock price. Guidance was reaffirmed but just short of the higher end of the ranges for 3 main reasons: slower ramp up of commercial print volumes, several US federal government cancellations and downgrades in federal efficiency programs and slightly softer booking trends within the ‘Corporates’ segment following an internal sales organizational change.

BSD Analysis:
Thomson Reuters sells mission-critical information and workflow tools to legal, tax, and corporate professionals who can’t afford errors. Once embedded, switching costs are cultural and operational, not just contractual. Subscription revenue dominates, providing stability through cycles. AI enhancements monetize best when layered onto trusted data sets. Investors still think of Reuters as a media company. In reality, it’s a professional software and data platform. Margins improve steadily with mix shift toward technology. Regulation and complexity entrench incumbents. This is information infrastructure that compounds quietly and predictably.

Pitch Summary:
FirstService Corporation released earnings in late October and while the quarter was not bad, with small misses primarily due to low catastrophic/weather-related business being low, the stock was punished as a result. Revenue of $1.45B vs FactSet $1.47B – 8 estimates, $1.45-1.48B, slightly missed consensus while EPS growth was in-line (Q3 EPS $1.76 ex-items vs FactSet $1.76 – 8 estimates, $1.71-1.80). Adjusted EBITDA came in ahead at $164.8M vs FactSet $167.1M [7 estimates, $165.6-168.9M]. Scott Patterson, CEO, commented: "We are pleased with the resilient growth in our consolidated Q3 results, despite weather-related and broader commercial macroeconomic headwinds which tempered the organic top-line within our Brands division. While we see these market challenges continuing to impact our performance in Q4, our businesses will collectively deliver a solid year of growth and profitability." The company trades at 16x Forward EV/EBITDA, below the long-term average at 18.1x (average –excluding early pandemic period at 16.7x).

BSD Analysis:
FirstService operates essential property services that homeowners, HOAs, and commercial clients cannot easily postpone or replace. Recurring contracts create durable, visible cash flow. Fragmentation across property services enables disciplined roll-up growth. Weather and housing cycles add noise but not thesis breaks. Scale improves route density and labor efficiency. Investors undervalue service businesses with low narrative appeal. Capital allocation has been conservative and effective. This is real estate services built on maintenance, not speculation. Assets need care regardless of sentiment.

Pitch Summary:
TerraVest Industries struggled for the first half of the quarter before a materially better second half. The company released strong fourth quarter earnings with sales for Q4 and FY2025 up 82% and 50% year-over-year. Net income for Q4 and FY2025 increased 54% and 34% year-over-year respectively, with contributions from new acquisitions and favorable non-recurring items. Adjusted EBITDA for Q4 and FY2025 grew 72% and 40% year-over-year, reflecting higher sales and acquisition synergies. The company also bought back 6.8M shares, reducing outstanding market float.

BSD Analysis:
TerraVest is a niche industrial manufacturer benefiting from infrastructure, energy, and agricultural end markets that don’t chase fashion cycles. Its businesses sell essential equipment where reliability matters more than branding. Earnings can look lumpy due to project timing, not weak demand. Investors often overlook TerraVest due to its small-cap profile. Yet disciplined capital allocation and bolt-on acquisitions steadily build value. Margins reflect engineering content rather than commodity exposure. Replacement demand provides a natural floor through downturns. This is industrial compounding without promotional noise. Quiet execution beats attention.

Pitch Summary:
Late in the quarter we bought Interactive Brokers (IBKR). Interactive Brokers is a leading automated global electronic broker that provides sophisticated investors with low-cost direct access to trade various asset classes across over 160 markets worldwide. The company represents a high-quality franchise defined by a fortress like balance sheet, a sticky client base with high switching costs, and an automated infrastructure that generates superior margins. We believe this low-cost advantage will continue to support market share gains, generate attractive account growth and produce sustainable mid-teens dividend growth.

BSD Analysis:
Interactive Brokers runs a brokerage like a software company, optimized for efficiency rather than marketing flash. Its low-cost, high-functionality platform attracts active traders, institutions, and global clients others can’t profitably serve. Higher interest rates boosted net interest income, but trading volatility is the real accelerator. Operating leverage is extreme because incremental accounts cost very little to serve. Investors focus on cyclical trading volumes and miss structural share gains. Automation and scale protect margins even during slow markets. Competition struggles to match pricing without destroying economics. This is financial infrastructure for serious users, not gamification. When markets move, IBKR prints.

Pitch Summary:
Zoetis (ZTS) released earnings earlier in November and while earnings per share was ahead of consensus, sales trailed modestly. The company also lowered its annual guidance, leading to a significant stock decline after the release. Throughout the year, ZTS struggled with fewer US veterinarian visits, new competition in key markets and ongoing negative social media coverage related to the company’s osteoarthritis pain drugs. In December, the board of directors declared a dividend increase of 6% from the quarterly rate paid in 2025. We exited the position prior to year end because of deteriorating dividend growth. We held ZTS for over 6 years and until 2025, the company had an annualized dividend growth rate of 22% during our holding period.

BSD Analysis:
Zoetis dominates animal health by selling products people don’t think twice about paying for. Pet humanization continues to push spend higher regardless of economic conditions. The company benefits from recurring treatments, vaccines, and diagnostics with real pricing power. Competition exists, but regulatory barriers and brand trust keep the field rational. Margins are consistently strong because R&D translates directly into differentiated products. Livestock adds diversification, but pets are the real growth engine. Zoetis doesn’t need innovation miracles — just steady execution. This is defensive growth done right. A rare healthcare name that sleeps well at night.

Pitch Summary:
Thermo Fisher Scientific’s (TMO) foundation for the Q4 rally, hitting a new 52-week high in late December, started with a strong Q3 earnings release near the end of October that were ahead of consensus expectations. TMO reported pharma clients are feeling more confident navigating the dynamic US policy environment and are planning U.S. capacity expansions with strong pipelines that TMO will benefit from via equipment sales and their CDMO network in coming years. The company expects growth to build in 2026 as headwinds abate, exiting the year at a run rate inline with its long-term organic revenue growth target of 3-6%.

BSD Analysis:
Thermo Fisher is the backbone of modern life sciences, selling the tools that research, testing, and manufacturing depend on every day. Its power comes from ecosystem scale — once Thermo is inside a lab, it tends to stay there. Biotech funding cycles create noise, but core consumables demand never disappears. Margins hold because customers value reliability over price. Acquisitions are disciplined and moat-widening rather than empire-building. Cash flow funds constant reinvestment without leverage stress. Thermo doesn’t need to pick winning drugs. It wins by enabling all of them. This is life-sciences infrastructure masquerading as a supplier.

Pitch Summary:
Applied Materials (AMAT) rose despite delivering mixed results in mid November. AI driven demand optimism, specifically around advanced logic and high bandwidth memory chips led to multiple expansion as there’s expected improvement in the wafer equipment market in 2026. Management issued a cautiously optimistic Q1 2026 outlook and forecast a significant uplift in the second half of calendar 2026 as spending shifts back toward AMAT’s strengths.

BSD Analysis:
Applied Materials is a core beneficiary of the semiconductor arms race, supplying tools that become more valuable as chips get harder to make. AI, advanced packaging, and leading-edge nodes all increase process complexity — and Applied gets paid per step. The company’s breadth across deposition, etch, and inspection creates cross-selling leverage competitors struggle to match. Cyclicality is unavoidable, but the baseline demand curve is rising. Services revenue smooths earnings across downturns. Customer concentration exists, but switching costs are brutal once fabs are configured. Capital intensity is high, but returns justify it. This is semiconductor infrastructure, not a gadget cycle. Applied wins as long as physics keeps getting harder.

Pitch Summary:
Eli Lilly (LLY) continues to benefit from the strength of its incretin portfolio. During the quarter, LLY reported Q3 results that were ahead of analyst expectations, driven by its GLP-1 franchise (Mounjaro and Zepbound). LLY now commands 58% of the US incretin market, and exited Q3 with 71% of new prescriptions, indicating further market share gains ahead. The strength led management to raise their annual guidance for the year for the third time this year. We believe LLY will carry this strength into 2026 when its oral GLP-1 drug (orforglipron) is expect to hit the market in the Spring. We believe the oral alternative will significantly expand the market globally due to the ease of use (no needle), less complex supply chain (much easier to manufacture and no cold storage chain needed) and lower cost.

BSD Analysis:
Eli Lilly is in the middle of one of the most powerful pharma cycles in decades, driven by obesity and diabetes drugs that actually work. Demand is overwhelming, turning manufacturing capacity into the real constraint. Pricing power is enormous, but political scrutiny comes with the territory. Unlike many pharma peers, Lilly pairs blockbuster execution with a credible pipeline beyond GLP-1s. Margins expand as scale catches up with demand. The balance sheet supports aggressive reinvestment without stress. This is not a short-term trade — it’s a therapeutic paradigm shift. Risks are real, but the earnings power reset is bigger. Lilly is rewriting what “growth pharma” looks like.